Thrombopoietin stimulates Myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 279-292

  Ferrajoli, Alessandra ^a   Talpaz, Moshe ^a   Kurzrock, Razelle ^a   Harris, David ^a   Van, Quin ^a   Estey, Elihu H ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hematopoiesis; Myelodysplastic syndrome; Thrombopoietin

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; MALE; MEGAKARYOPOIESIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031844968     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057541     Document Type: Article

References (50)

1. Hamblin, T. (1992). Clinical feature of MDS. Leuk Res. 16, 89-93.
2. Weisdorf, D. J., Oken, M. M., Johnson, G. J. and Rydell, R. E. (1983). Chronic myelodysplastic syndrome: short survival with and without evolution to acute leukemia. Br J Haematol. 59, 619-700.
3. Sanz, G. F., Sanz, M. A., Vallespi, T., Canizo, M. C., Torrabadella, M., Garcia, S., Irriguible, D. and San Miguel, J. F. (1989). Two regression models and scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multi-variate analysis of prognostic factors in 370 patients, Blood, 74, 395-408.
4. Mufti, G. J., Stevens, J. R., Oscier, D. G., Hamblin, T. J. and Machin, D. (1985). Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol, 59, 425-433.
5. Cheson, B. D. and Simon, R. (1987). Low-dose ARA-C in acute non lymphocytic leukemia and Myelodysplastic syndromes: a review of 20 years experience. Semin Oncol. 14 (suppl 1), 126-133.
6. Estey, E., Thall, P., Kantarjian, H., Pierce, S. and Beran, M. , (1996). Diagnosis of RAEB or RAEB-T, Rather than AML, does not negatively influence outcome of anti-AML chemotherapy. Blood, 88 (suppl 1), 292a (abstract).
7. Dunbar, C. and Nienhuis, A. W. (1995). Myelodysplastic Syndromes. In: Handin, R.I., Lux, S.E. and Stossel, T.P. (eds.). Blood: Principles and Practice of Hematology. (J. B. Lippincot, Philadelphia), p. 377.
8. Anderson, J. E., Appelbaum, F. R., Fisher, L. D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W. I., Bryant, E., Buckner, C. D., Doney, K., Martin, P. J., Sanders, J. E., Sullivan, K. M., Thomas, E. D., Whitherspoon, R. P., Hansen, J. A. and Sturb, R. (1993). Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677-681.
9. Ohno, R., Naoe, T., Hirano, M., Kobayashi, M., Hirai, H., Tubaki, K. and Oh, H. (1993). Treatment of myelodysplastic syndromes with all-trans retinoid acid. Blood, 81, 1152-1154.
10. Koeffler, H. P., Hirji, K. and Itri, L. (1985). 1.25-dihydroxyvitamin D3; in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep, 69, 1399-1407.
11. Cines, C. B., Cassileth, P. A. and Kiss, J. E. (1985). Danazol therapy in myelodysplasia. Ann Intern Med, 103, 58-60.
12. Negrin, R., Stein, R., Vardiman, J., Doherty, K., Cornwell, J., Krantz, S. and Greenberg. P. L. (1993). Treatment of the anemias of MDS using recombinant human granulocyte colonystimulating factor. Blood, 82, 737-743.
13. Willemze, R., van der Lely, N., Zwierzina, H., Suciu, S., Solbu, G., Gerhartz, H., Labar, B., Visani, G., Peetermans, M. E., Jacobs, A., Stryckmans, P., Fenaux, P., Haak, H. L., Ribeiro, M. M., Baumelou, E., Baccarani, M., Mandelli, F., Jaksic, B., Louwagie, A., Thyss, A., Hayat, M., de Cataldo, F., Stern, A. C. and Zittoun, R. (1992). A randomized phase I/II multicenter study of recombinant human GM-CSF therapy for patients with myelodysplastic syndromes and a relative low risk to acute leukemia. Ann Hematol, 64, 173-180.
14. Ganser, A., Ottman, O. G., Seipelt, G., Lindemann, A., Hess, U., Geissler, G., Maurer, A., Frisch, J., Schulz, G., Mertelsmann, R. and Hoelzer, D. (1993). Fffect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes. Leukemia. 7, 696-701.
15. Hellstrom, E., Birgegaard, G., Lockner, D., Helmers, C., Ost, A. and Wide. L. (1991). Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol. 47, 355-366.
16. Kurzrock, R., Talpaz, M., Estey, E., O'Brien, S., Estrov, Z. and Gutterman, J. U. (1991). Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. Leukemia, 5, 985-990.
17. Cheson, B. D. (1990). The Myelodysplastic Syndromes: Current approaches to therapy. Ann Intern Med, 112, 932-941.
18. Lok, S., Kaushansky, K., Holly, R. D., Kuijper, J. L., Lofton-Day, C. E., Oort, P. J., Grant, F. J., Heipel, M. D., Burkhead, S. K., Kramer, J. M., Bell, L. A., Sprecher, C. A., Blumberg, H., Johnson, R., Prunkard, D., Ching, A. F. T., Mathewes, S. L., Bailey, M. C., Forstrom, J. W., Buddle, M. M., Osborn, S. G., Evans, S. J., Sheppard, P. O., Presnell, S. R., O'Hara, P. J., Hagen, F. S., Roth, G. J. and Foster, D. C. (1994). Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-568.
19. De Sauvage, F. J., Hass, P. E., Spenser, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., Darbonne, W. C., Henzel, W. J., Wong, S. C., Kuang, W. J., Oles, K. J., Hultgren, B., Solberg, L. A., Goeddel, D. V. and Eaton, D. L. (1994). Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-MpI ligand. Nature, 369, 533-538.
20. Bartley, T. D., Begenberger, J., Hunt, P., Li, Y. S., Martin, F., Chang, M. S., Samal, B., Nichol, J. L., Swift, S., Johnson, M. J., Hsu, R. Y., Parker, V. P., Suggs, S., Skrine, J. D., Merewether, L. A., Clogston, C., Hsu, E., Hokom, M. M., Hornkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L., Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, S. D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M. C. T., Pacifici, R., Ponting, I., Saris, C., Wen, D., Yung, Y. P., Lin, H. and Bosselman, A. (1994). Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI. Cell, 77, 1117-1124.
21. Miyazaki, H., Kato, T., Ogami, K., Iwamatsu, A., Shimada, Y., Souma, Y., Akahori, H., Horie, K., Kokubo, A., Kudo, Y., Maeda, E., Kawamura, K. and Sudo, T. (1944). Isolation and cloning of a novel thrombopoietic factor. Exp Hematol, 22, 838-846.
22. Kaushansky, K. ( 1995). Thrombopoietin: the primary regulator of platelet production. Blood, 86, 419-431.
23. Papayannopoulou, T. (1996). Biological effects of thrombopoietin, the MpI ligand, and its therapeutic potential. Cancer Chemother Pharmacol, 38, S69-S73.
24. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P. and Vainchenker, W. (1995). The MpI-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood, 86, 2516-2521.
25. Kaushansky, K., Broudy, V. C., Lin, N., Jorgensen, M. J., McCarty, J., Fox, N., Zucker-Franklin, D. and Lofton-Day, C. (1995). Thrombopoietin, the MpI ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA, 92, 3234-3239.
26. Kobayashi. M., Laver, J. H., Kato, T., Miyazaki, H. and Ogawa, M. (1995). Recombinant human thrombopoietin (MpI ligand) enhances proliferation of erythroid progenitors. Blood, 86, 2494-2499.
27. Kaushansky, K., Broudy, V. C., Grossman, A., Humes, J., Lin, N., Hong, P., Sprugel, K. H., Bailey, M. C., Papayannopoulou, T. and Forstrom, J. (1995). Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery following myelosuppressive therapy. J Clin Invest, 96, 1683-1693.
28. Papayannopoulou, T., Brice, M., Farrer, D. and Kaushansky, K. (1996). Insights into cellular mechanism of erythropoietin-thrombopoietin synergy. Exp Hematol, 24 60-664.
29. Drexler, H. G. and Quentmeier, H. (1996). Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia, 10, 1405-1421.
30. Chadwick, D E., Williams, D. P., Niho, Y., Murphy, J. R. and Minden, M. D. (1993). Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells. Leukemia and Lymphoma, 11, 249-262.
31. Papayannopoulou,T., Nakamoto, B., Kurachi, S., Tweeddale, M. and Messner, H. (1988). Surface antigen profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood, 72, 1029-1038.
32. Shaw, G. M., Levy, P. C. and LoBuglio, A. F. (1978). Human monocyte antibody-dependent cell-medicated cytotoxicity to tumor cells. J Clin Invest, 62, 1172-1180.
33. Estrov, Z., Grunberger, T., Chan, H. S. L, and Freeman, M. H. (1986). Juvenile Chronic Myelogenous Leukemia: characterization of the disease using cell cultures. Blood, 67, 1382-1387.
34. Strauss, L. C., Trischmann, T. M., Rowley, S. D., Wiley, J. M, and Civin, C. I. (1991). Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol Oncol, 13, 217-221.
35. Bertoncello, I., Bradley, R. and Watt, S. M. (1991). An improved negative immunomagnetic selection strategy for the purification of primitive hemopoietic cells from normal bone marrow. Exp Hematol, 19, 95-100.
36. Re, G. G., Estrov, Z., Antoun, G. R., Felix, E. A., Pinkel, D. P. and Zipf, T. F. (1991). Differentiation in B-precursors acute lymphoblastic leukemia cell population with CD34-positive subpopulations. Blood, 78, 575-580.
37. Fauser, A. A. and Messner, H. A. (1978). Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood, 52, 1243-1248.
38. Messner, H. A. and Fauser, A. A. (1980). Culture studies of human pluripotent hematopoietic progenitors. Blut, 41, 327-333.
39. Estrov, Z., Cohen, A., Gelfand, E. W. and Freedman, M. H. (1988). Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine-arabinoside, methotrexate and daunorubicine cytotoxicity. Am J Pediatr Hematol Oncol, 10, 288-291.
40. Buick, R. N., Till, J. E. and McCulloch, E. A. (1977). A colony assay for proliferate blast cells circulating in myeloblastic leukemia. Lancet, 1, 862-864.
41. Minden, M. D., Buick, R. N. and McCulloch, E. A. (1979). Separation of blast cells and T lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood, 54, 186-189.
42. Freedman, M. H., Chan, H. S. L. and Chang, L. (1986). Childhood erythroleukemia. Studies on pathogenesis using colony assays. Am J Pediatr Hematol Oncol, 8, 2-9.
43. Foster, D. C., Sprecher, C. A., Grant. F. J., Kramer, J. M., Kuijper, Holly, R. D., Whitmore, T. E., Heipel, M. D., Bell, L. A. and Ching, A. F. (1994). Human thrombopoietin: gene structure, c-DNA sequence, expression and chromosomal localization, Proc Natl Acad Sci USA, 91, 13023-13027.
44. Sohma, Y., Akahori, H., Seki, N., Hori, T. A., Ogami, K., Kato, T., Shimada, Y., Kawaruma, K. and Miyazaki, H. (1994). Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett, 353, 57-61.
45. Suzukawa, K., Satoh, H., Tanikawi, M., Yokota, J. and Morishita, K. (1995). The human thrombopoietin gene is located on chromosome 3q 26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia, 9, 1328-1331.
46. Alexander, W. S., Roberts, A. W., Nicola, N. A., Li, R. and Metcalf, D. (1996). Deficiencies in progenitor cells multiple hematopoietic lineages and defective megakaryocytopoisis in mice lacking the thrombopoietin receptor c-MpI. Blood, 87, 2162-2170.
47. Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Ishikawa, J., Horikawa, Y., Hashimoto, K., Moriyama, Y., Tsujimura, T., Nishiura, T., Miyazaki, H. and Matsuzawa, Y. (1995). Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood, 86, 703-709.
48. Quentmeier, H., Zaborski, M., Graf, G., Ludwig, W. D. and Drexler, H. G. (1996). Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemic cell lines. Leukemia, 10, 297-310.
49. Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Horikawa, Y., Ishikawa, J., Kitayama, H., Nishiura, T., Tomiyama, Y., Miyazaki, H. and Matsuzawa, Y. (1996). The biological properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood, 88, 3074-3082.
50. Motoji, T., Takanashi, M., Motomura, S., Yan-Hua, W., Shiozaki, H., Aoyama, M. and Mizoguchi, H. (1996). Growth stimulatory effect of thrombopoietin in the blast cells of acute myelogenous leukemia. Br J Haematol, 94, 513-516.